secwatch.observer — SEC 8-K summary
======================================

Issuer:     Co-Diagnostics, Inc. (CODX)
CIK:        0001692415
Form:       8-K
Filed at:   2025-04-28T23:59:59+00:00
Accession:  0001641172-25-006324
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Co-Diagnostics amends equity distribution agreement, adds Clear Street as sales agent, up to $17.1M remaining
--------------------------------------------------------------------------------

- Amended equity distribution agreement adds Clear Street LLC as sales agent alongside Piper Sandler, effective April 25, 2025.
- Aggregate offering price up to $17,111,650 remains available; Co-Diagnostics had sold 833,806 shares under prior $50M facility.
- Sales agents receive 3.0% commission on gross sales price; reimbursement capped at $125k setup, $35k execution, $54k for Q3 2024, and $15k per subsequent quarter.
- ATM sales to be made on Nasdaq; settlement on first business day after sale; no escrow arrangement.
- Company will report quarterly the number of shares sold and net proceeds from the program.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1692415/000164117225006324/0001641172-25-006324-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1692415/000164117225006324/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-006324

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer